Highlight Pharmaceutical is Drug Discovery in China that focus on distinctive pharmacological business. Founded in 2017. They cover business area such as developer, drug, immune disease, tumor, innovative product line, global competitive advantage, its distinctive pharmacological, biological and clinical capability, patient, safe and affordable treatment.
2017
( 7 years old in 2024 )
Distinctive Pharmacological
-
Room 205, Block B, Baoli Zhongke Plaza
No. 105 Lanyue Road, Huangpu District
Guangzhou, Guangdong
China
Private
developerdrugimmune diseasetumorinnovative product lineglobal competitive advantageits distinctive pharmacological, biological and clinical capabilitypatientsafe and affordable treatment
* We use standard office opening hours in near Highlight Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Highlight Pharmaceutical is Drug Discovery business from China that founded in 2017 (7 years old in 2024), Highlight Pharmaceutical business is focusing on Distinctive Pharmacological.
Highlight Pharmaceutical headquarter office and corporate office address is located in Room 205, Block B, Baoli Zhongke Plaza No. 105 Lanyue Road, Huangpu District Guangzhou, Guangdong China.
Highlight Pharmaceutical was founded in China.
In 2024, Highlight Pharmaceutical is currently focus on distinctive pharmacological sector.
Above is snippet of Google Trends for "distinctive pharmacological" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Highlight Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
